Clinicopathological significance of VEGF and pAkt expressions in oral squamous cell carcinoma

References

• Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie T-X, Zhang J, Wang J, et al. 2011. Exome sequencing of headand neck squamous cell carcinoma reveals inactivating mutations inNOTCH1. Science. 6046:1154–1157. doi: https://doi.org/10.1126/science.1206923
   Google Scholar
• Alyasiri NS, Mehdi SJ, Alam MS, Ali A, Mandal AK, Gupta S, Singh I, Rizvi MM. 2012. PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. J Cancer Res Clin Oncol. 138(1):103–109. doi: https://doi.org/10.1007/s00432-011-1077-y
   Google Scholar
• Babiker AY, Almatroudi A, Allemailem KS, Husain NEOS, Alsammani MA, Alsahli MA, Rahmani AH. 2018. Clinicopathologic aspects of squamous cell carcinoma of the uterine cervix: role of PTEN, BCL2 and P53. Appl. Sci. 8:2124. doi: https://doi.org/10.3390/app8112124
   Google Scholar
• Ben-Izhak O, Laster Z, Akrish S, Cohen G. 2008. Nagler RM: TUNEL as a tumor marker of tongue cancer. Anticancer Res. 28:2981–2986.
   Web of Science ®Google Scholar
• Brazil DP, Yang ZZ, Hemmings BA. 2004. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci. 29(5):233–242. doi: https://doi.org/10.1016/j.tibs.2004.03.006
   PubMed Web of Science ®Google Scholar
• Camisasca DR, Honorato J, Bernardo V, da Silva LE, da Fonseca EC, de Faria PA, Dias FL. 2009. Lourenco SQ: expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol. 45:225–233. doi: https://doi.org/10.1016/j.oraloncology.2008.05.021
   Google Scholar
• Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 6(4):389–395. doi: https://doi.org/10.1038/74651
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature. 407:249–257. doi: https://doi.org/10.1038/35025220
   PubMed Web of Science ®Google Scholar
• Cheng D, Liang B, Li Y. 2013. Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer. PLoS One. 8:e55309. doi: https://doi.org/10.1371/journal.pone.0055309
   Google Scholar
• Cheung M, Testa JR. 2013. Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets. 13(3):234-244. doi: https://doi.org/10.2174/1568009611313030002
   Google Scholar
• Conway DI, Hashibe M, Boffetta P, Wunsch-Filho V, Muscat J, La Vecchia C, Winn DM. 2009. Enhancing epidemiologic research on head and neck cancer: INHANCE – The international head and neck cancer epidemiology consortium. Oral Oncol. 45:743–746. doi: https://doi.org/10.1016/j.oraloncology.2009.02.007
   Google Scholar
• Courtney KD, Corcoran RB, Engelman JA. 2010. The PI3K pathway as drug target in human cancer. J ClinOncol. 28( ):1075–1083. doi: https://doi.org/10.1200/JCO.2009.25.3641
   PubMed Web of Science ®Google Scholar
• Ferrara N. 2001. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 280:C1358–C1366. doi: https://doi.org/10.1152/ajpcell.2001.280.6.C1358
   PubMed Web of Science ®Google Scholar
• Gasinska A, Fowler JF, Lind BK. 2004. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. ActaOncol. 43:657–666.
   Google Scholar
• Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493–501. doi: https://doi.org/10.1083/jcb.119.3.493
   PubMed Web of Science ®Google Scholar
• Gkiozos I, Tsagouli S, Charpidou A, Grapsa D, Kainis E, Gratziou C, Syrigos K. 2015. Levels of vascular endothelial growth factor in serum and pleural fluid are independent predictors of survival in advanced non-small cell lung cancer: results of a prospective study. Anticancer Res. 35:1129–1137.
   PubMed Web of Science ®Google Scholar
• Hasina R, Lingen MW. 2001. Angiogenesis in oral cancer. J Dent Educ. 65:1282–1290. doi: https://doi.org/10.1002/j.0022-0337.2001.65.11.tb03489.x
   Google Scholar
• Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. 2005. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 4(12):988–1004. doi: https://doi.org/10.1038/nrd1902
   PubMed Web of Science ®Google Scholar
• Hockenbery DM. 1994. Bcl-2 in cancer, development and apoptosis. J Cell Sci. 18:51–55. doi: https://doi.org/10.1242/jcs.1994.Supplement_18.7
   Google Scholar
• Hou X, Wei JC, Fu JH, Wang X, Luo RZ, He JH, Zhang LJ, Lin P, Yang HX. 2015. Vascular endothelial growth factor is a Useful Predictor of Postoperative Distant metastasis and survival prognosis in Esophageal squamous cell carcinoma. Ann SurgOncol. 22:3666–3673.
   Google Scholar
• Kim S-K, Park S-G, Kim K-W. 2015 Feb. Expression of vascular endothelial growth factor in oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg. 41(1):11–18. doi: https://doi.org/10.5125/jkaoms.2015.41.1.11
   Google Scholar
• Kumar A, Purohit R. 2013. Cancer associated E17K mutation causes rapid conformational drift in AKT1 Pleckstrin Homology (PH) Domain. PLoS ONE. 8(5). Article ID e64364. doi: https://doi.org/10.1371/annotation/7c19edf3-4648-45de-8132-16092fc4bf40
   Google Scholar
• Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. 2005. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 131(9):624–630. doi: https://doi.org/10.1007/s00432-005-0003-6
   PubMed Web of Science ®Google Scholar
• Lamaroon A, Krisanaprakornkit S. 2009. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. Oral Oncol. 45:e175–e179. doi: https://doi.org/10.1016/j.oraloncology.2009.06.003
   Google Scholar
• Lim J, Kim J-H, Paeng J-Y, Kim M-J, Hong S-D, Lee J-I, Hong S-P. 2005 Nov. Prognostic value of activated Akt expression in oral squamous cell carcinoma. J ClinPathol. 58(11):1199–1205.
   Google Scholar
• Lockshin RA, Williams CM. 1965. Programmed cell death-I. Cytology of degeneration in the intersegmental muscles of the Pernyi silkmoth. J Insect Physiol. 11(2):123–133. doi: https://doi.org/10.1016/0022-1910(65)90099-5
   PubMedGoogle Scholar
• Lopez-Knowles E, O'Toole SA, McNeil CM, Millar EK, Qiu MR, Crea P, Daly RJ, Musgrove EA, Sutherland RL. 2010. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int J Cancer. 126(5):1121–1131. doi: https://doi.org/10.1002/ijc.24831
   PubMed Web of Science ®Google Scholar
• Lyu J, Song H, Tian Z, Miao Y, Ren G, Guo W. 2016. Predictive value of pAKT/PTEN expression in oral squamous cell carcinoma treated with cetuximab-based chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 121(1):67–72. doi: https://doi.org/10.1016/j.oooo.2015.09.002
   Google Scholar
• Manning BD, Cantley LC. 2007. AKT/PKB signaling: navigating downstream. Cell. 129(7):1261–1274. doi: https://doi.org/10.1016/j.cell.2007.06.009
   PubMed Web of Science ®Google Scholar
• Mao L, Hong WK. 2004. Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell. 5:311–316. doi: https://doi.org/10.1016/S1535-6108(04)00090-X
   PubMed Web of Science ®Google Scholar
• Massano J, Regateiro FS, Januário G, Ferreira A. 2006. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 102(1):67–76. doi: https://doi.org/10.1016/j.tripleo.2005.07.038
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Gupta A, Singh M, Ibrahim R. 2006. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer. 5:11. doi: https://doi.org/10.1186/1476-4598-5-11
   PubMed Web of Science ®Google Scholar
• Nakano R. 1997. Apoptosis: gene-directed cell death. An Overview. Horm. Res. 48(Suppl.3):2–4. doi: https://doi.org/10.1159/000191292
   Google Scholar
• Naruse T, Kawasaki G, Yanamoto S, Mizuno A, Umeda M. 2011. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway. Anticancer Res. 31:4429–4437.
   PubMed Web of Science ®Google Scholar
• Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609–619. doi: https://doi.org/10.1016/0092-8674(93)90509-O
   PubMed Web of Science ®Google Scholar
• Pérez-Tenorio G, Stål O. 2002. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br J Cancer. 86(4):540–545. doi: https://doi.org/10.1038/sj.bjc.6600126
   PubMed Web of Science ®Google Scholar
• Rahmani A, Alzohairy M, Khadri H, Mandal AK, Rizvi MA. 2012. Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke. Int J ClinExpPathol. 5:195–202.
   Web of Science ®Google Scholar
• Rahmani AH, Babiker AY, AlWanian WM, Elsiddig SA, Faragalla HE, Aly SM. 2015. Association of cytokeratin and vimentin protein in the genesis of transitional cell carcinoma of urinary bladder patients. Dis Markers. 2015:204759. doi: https://doi.org/10.1155/2015/204759
   Google Scholar
• Sambandam Y, Sakamuri S, Balasubramanian S, Haque A. 2016. RANK ligand modulation of autophagy in oral squamous cell carcinoma tumor cells. J Cell Biochem. 117(1):118–125. doi: https://doi.org/10.1002/jcb.25255
   Google Scholar
• Singhal A, Hadi R, Chaturvedi A, Sharma ID, Misra S, Husain N. 2016. Vascular endothelial growth factor expression in oral cancer and its role as a predictive marker: a prospective study. Saudi Surg J. 4(2):52–56. doi: https://doi.org/10.4103/2320-3846.183673
   Google Scholar
• Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, et al. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science. 6046:1157–1160. doi: https://doi.org/10.1126/science.1208130
   Google Scholar
• Strasser A, O'Connor L, Dixit VM. 2000. Apoptosis signaling. Annu Rev Biochem. 69:217–245. doi: https://doi.org/10.1146/annurev.biochem.69.1.217
   PubMed Web of Science ®Google Scholar
• Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. doi: https://doi.org/10.1126/science.7878464
   PubMed Web of Science ®Google Scholar
• Toulany M, Maier J, Iida M, Rebholz S, Holler M, Grottke A, Jüker M, Wheeler DL, Rothbauer U, Rodemann HP. 2017. Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells. Cell Death Discov. 3:170722017. doi: https://doi.org/10.1038/cddiscovery.2017.72
   Google Scholar
• Tsai HL, Yang IP, Lin CH, Chai CY, Huang YH, Chen CF, Hou MF, Kuo CH, Juo SH, Wang JY. 2013. Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection. Int J Colorectal Dis. 28:415–424. doi: https://doi.org/10.1007/s00384-012-1570-z
   Google Scholar
• Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. doi: https://doi.org/10.1038/nrc839
   PubMed Web of Science ®Google Scholar
• Watanabe I, Toyoda M, Okuda J, Tenjo T, Tanaka K, Yamamoto T, Kawasaki H, Sugiyama T, Kawarada Y, Tanigawa N. 1999. Detection of apoptotic cells in human colorectal cancer by Two different in situ methods: antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick End-labeling (TUNEL) methods. Jpn J Cancer Res. 90(2):188–193. doi: https://doi.org/10.1111/j.1349-7006.1999.tb00732.x
   Google Scholar
• Yang E, Korsmeyer SJ. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88:386–401. doi: https://doi.org/10.1182/blood.V88.2.386.bloodjournal882386
   PubMed Web of Science ®Google Scholar
• Yavari K. 2018. Anti-angiogenesis therapy of cancer cells using 153Sm-Bevasesomab. Emerg Sci J. 2(3):130–139. doi: https://doi.org/10.28991/esj-2018-01136
   Google Scholar
• Yuan TL, Cantley LC. 2008. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 27:5497–5510. doi: https://doi.org/10.1038/onc.2008.245
   PubMed Web of Science ®Google Scholar
• Zare H. 2019. Effects of Salvia Officinalis Extract on the breast cancer cell Line. SciMedicine Journal. 1:25–29. doi: https://doi.org/10.28991/SciMedJ-2019-0101-4
   Google Scholar
• Zhang H, Peng W, Zhang Y. 2014 Jun. Detection of cell apoptosis in pelvic lymph nodes of patients with cervical cancer after neoadjuvant chemotherapy. J Int Med Res. 42(3):641–650. doi: https://doi.org/10.1177/0300060513506328
   Google Scholar